Oxazole- and Imidazole-Based Ser-Leu Dipeptide Mimetics in Potent Inhibitors of Antigen Presentation by MHC Class II DR Molecules

Author： Sarabu Ramakanth   Bolin David R.   Campbell Robert   Cooper Joel P.   Cox Donald   Gaizband Diana   Makofske Raymond   Nagy Zoltan   Olson Gary L.  

Publisher： Taylor & Francis Ltd

ISSN： 1055-9612

Source： Drug Design and Discovery, Vol.18, Iss.1, 2002-03, pp. : 3-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanisms of MHC class I-restricted antigen presentation

By Hofmann Matthias   Nussbaum Alexander K   Emmerich Niels PN   Stoltze Lars   Schild Hansjörg  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 3, 2001-06 ,pp. : 379-393

Informa Healthcare

Access to resources Recommend Favorite

Endothelial Expression of MHC Class II Molecules in Autoimmune Disease

By  

Current Pharmaceutical Design, Vol. 10, Iss. 2, 2004-01 ,pp. : 129-143

Bentham Science Publishers

Access to resources Recommend Favorite

Imidazole-based Derivatives as Potential Anti-platelet Inhibitors: DFT and Molecular Docking Study

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 9, 2016-11 ,pp. : 888-896

Bentham Science Publishers

Access to resources Recommend Favorite

P38 MAP Kinase Inhibitors: Evolution of Imidazole-Based and Pyrido- Pyrimidin-2-One Lead Classes

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 10, 2005-09 ,pp. : 987-1003

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Tumor-Associated Antigens to the MHC Class I Presentation Pathway

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 2, 2007-06 ,pp. : 99-109

Bentham Science Publishers

Access to resources Recommend Favorite